TheraPb Phase 1b: First-in-Human Dose-Escalation and Optimization Study of 212Pb-ADVC001 in PSMA-Positive Metastatic Androgen Pathway Modulation–Resistant Prostate Cancer


Aaron R. Hansen, David A. Pattison, Jeffrey C. Goh, Stanley S. Ngai, Aravind S. Ravi…
AdvanCell Admin4 November 2026











